Name
ARCALIS, Inc.
What We Do
ARCALIS is a leading CDMO specializing in mRNA and saRNA vaccines and therapeutics. The company provides end‑to‑end support from early discovery and sequence optimization to CMC development and GMP manufacturing. With flexible R&D services including small‑scale, multi‑product production and advanced LNP formulation capabilities, ARCALIS enables the development of RNA medicines for infectious diseases, rare diseases, oncology, regenerative medicine, and genome editing.
Founded
2021
Website
https://corp.arcalis.co.jp/en/
Categories (3)
Fill & Finish, Gene Therapy, Nucleotides
Phone
81471371812
Address
226-39
Koshiwa, Chiba 277-0871
Japan
LinkedIn

Listings

Relevance
RNA–LNP Therapeutics：From Discovery to Commercial
RNA–LNP Therapeutics：From Discovery to Commercial 104
#714
ARCALIS, Inc.

Share:

Contacts

Akiko Yanagiya
ARCALIS, Inc. ARCALIS, Inc.
Tetsuo Yoshida